SCIENCE ADVISORY BOARD

Professor Coen

Professor Coen

Clive Coen is Professor of Neuroscience at King’s College London. His multidisciplinary research includes the neuroanatomical analysis of regulatory systems. This is influenced by his longstanding interest in comparative and evolutionary aspects of these systems. He has served on the board of several learned societies and scientific journals and as chief consultant for seven BBC documentaries. Currently he is Editor of Neuroendocrinology and Chair of the Rationalist Association.

View Clive’s LinkedIn page

Dr Mohs

Dr Mohs

Richard Mohs is the Chief Scientific Officer for the Global Alzheimer’s Platform (GAP) Foundation. He worked for Eli Lilly and Company holding several leadership positions including Vice President for Neuroscience Early Clinical Development (2012-2015) and Leader of the Global Alzheimer’s Drug Development Team (2007-2012). Dr. Mohs received the Ph.D. is psychology from Stanford University and completed postdoctoral training in pharmacology at the Stanford Medical School.

View Richard’s LinkedIn page

Professor Herrling

Professor Herrling

Non-Executive Director

Professor Paul Herrling was Head of Corporate Research at Novartis. He is also Chairman of the Board of the Novartis Institute for Tropical Diseases in Singapore, an endeavour to advance medical research in the area of tropical infectious diseases, which historically have received little drug-research funding. Prior to this, Paul Herrling was Head of Global Research at Novartis Pharma and a member of the Pharma Executive Committee (PEC), he is a member of the Board of the Genomics Institute of the Novartis Research Foundation in La Jolla California and he serves on the boards of several other research institutions. Paul Herrling is also Professor of Drug Discovery Science at the University of Basel, Switzerland. He obtained his doctorate in 1975 at the University of Zurich and was a post-doctorate fellow at the Neuropsychiatric Institute at the University of California, Los Angeles (UCLA).

View Paul’s LinkedIn page

 

Dr Gary Manchee

Dr Gary Manchee

Dr Gary Manchee has a PhD on species differences in drug metabolism and he is a co-author on 26 published papers.
Over 30-years’ experience in the pharmaceutical industry and as the Director of Drug Metabolism and Pharmacokinetics in Psychiatry, Respiratory & inflammatory,
and Immuno-inflammatory disease areas within Drug Discovery at GSK, he progressed 35 new compounds into early and late-stage development.

View Gary’s LinkedIn page

T: +44 (0)1235 420 085
E: info@neuro-bio.com

NBO logo

© All Rights Reserved NeuroBio

NeuroBio logo

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Neuro-Bio

You have Successfully Subscribed!